HEADER TRANSFERASE 07-NOV-22 8HE7 TITLE ADP-RIBOSYLTRANSFERASE 1 (PARP1) CATALYTIC DOMAIN BOUND TO A TITLE 2 QUINAZOLINE-2,4(1H,3H)-DIONE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 1, PROCESSED C-TERMINUS; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: POLY [ADP-RIBOSE] POLYMERASE 1,89-KDA FORM; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP1, ADPRT, PPOL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DNA ADP-RIBOSYLTRANSFERASE 1, PARP1, INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR X.Y.WANG,J.ZHOU,B.L.XU REVDAT 1 08-NOV-23 8HE7 0 JRNL AUTH J.ZHOU,T.DU,X.WANG,H.YAO,J.DENG,Y.LI,X.CHEN,L.SHENG,M.JI, JRNL AUTH 2 B.XU JRNL TITL DISCOVERY OF QUINAZOLINE-2,4(1 H ,3 H )-DIONE DERIVATIVES JRNL TITL 2 CONTAINING A PIPERIZINONE MOIETY AS POTENT PARP-1/2 JRNL TITL 3 INHIBITORS─DESIGN, SYNTHESIS, IN VIVO ANTITUMOR JRNL TITL 4 ACTIVITY, AND X-RAY CRYSTAL STRUCTURE ANALYSIS. JRNL REF J.MED.CHEM. V. 66 14095 2023 JRNL REFN ISSN 0022-2623 JRNL PMID 37843892 JRNL DOI 10.1021/ACS.JMEDCHEM.3C01152 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.42 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 3 NUMBER OF REFLECTIONS : 41238 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 2003 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.4200 - 5.0600 0.99 3129 169 0.1898 0.2151 REMARK 3 2 5.0600 - 4.0200 0.99 2998 133 0.1522 0.2168 REMARK 3 3 4.0200 - 3.5100 0.86 2566 141 0.1692 0.2360 REMARK 3 4 3.5100 - 3.1900 0.86 2534 137 0.1897 0.2270 REMARK 3 5 3.1900 - 2.9600 0.99 2917 148 0.1960 0.2440 REMARK 3 6 2.9600 - 2.7800 0.99 2894 157 0.1989 0.2635 REMARK 3 7 2.7800 - 2.6500 0.91 2662 139 0.2096 0.2937 REMARK 3 8 2.6500 - 2.5300 1.00 2877 150 0.2105 0.2666 REMARK 3 9 2.5300 - 2.4300 1.00 2884 181 0.2038 0.2808 REMARK 3 10 2.4300 - 2.3500 1.00 2916 145 0.2076 0.3212 REMARK 3 11 2.3500 - 2.2800 1.00 2945 121 0.2138 0.2442 REMARK 3 12 2.2800 - 2.2100 0.83 2378 124 0.2166 0.2979 REMARK 3 13 2.2100 - 2.1500 0.97 2852 121 0.2196 0.3059 REMARK 3 14 2.1500 - 2.1000 0.93 2683 137 0.2345 0.3321 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.238 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.080 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.94 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 5702 REMARK 3 ANGLE : 0.546 7706 REMARK 3 CHIRALITY : 0.041 850 REMARK 3 PLANARITY : 0.003 980 REMARK 3 DIHEDRAL : 5.944 776 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8HE7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 14-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1300033471. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-AUG-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979183 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41898 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.090 REMARK 200 RESOLUTION RANGE LOW (A) : 46.420 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.15500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 6.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.14150 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 11.17 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 7CMW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.5 M (NH4)2SO4, 100 MM TRIS-HCL, PH REMARK 280 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.21400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 81.40250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.00350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.40250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.21400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.00350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16510 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16540 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 980 -102.46 -66.40 REMARK 500 HIS B 826 43.84 -99.23 REMARK 500 ASP B 914 69.35 -165.31 REMARK 500 REMARK 500 REMARK: NULL DBREF 8HE7 A 662 1011 UNP P09874 PARP1_HUMAN 662 1011 DBREF 8HE7 B 662 1011 UNP P09874 PARP1_HUMAN 662 1011 SEQADV 8HE7 ALA A 762 UNP P09874 VAL 762 VARIANT SEQADV 8HE7 ALA B 762 UNP P09874 VAL 762 VARIANT SEQRES 1 A 350 LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU ILE LYS SEQRES 2 A 350 MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA MET VAL SEQRES 3 A 350 GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU GLY LYS SEQRES 4 A 350 LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER ILE LEU SEQRES 5 A 350 SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SER ASP SEQRES 6 A 350 SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR THR LEU SEQRES 7 A 350 ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO LEU LEU SEQRES 8 A 350 ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU MET LEU SEQRES 9 A 350 ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER LEU LEU SEQRES 10 A 350 ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO ILE ASP SEQRES 11 A 350 VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS VAL VAL SEQRES 12 A 350 ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG LYS TYR SEQRES 13 A 350 VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA TYR ASP SEQRES 14 A 350 LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG GLU GLY SEQRES 15 A 350 GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU HIS ASN SEQRES 16 A 350 ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR ASN PHE SEQRES 17 A 350 ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA PRO PRO SEQRES 18 A 350 GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS GLY ILE SEQRES 19 A 350 TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN TYR CYS SEQRES 20 A 350 HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE LEU LEU SEQRES 21 A 350 GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU LYS HIS SEQRES 22 A 350 ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS HIS SER SEQRES 23 A 350 VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SER ALA SEQRES 24 A 350 ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU GLY THR SEQRES 25 A 350 GLY ILE SER SER GLY VAL ASN ASP THR SER LEU LEU TYR SEQRES 26 A 350 ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL ASN LEU SEQRES 27 A 350 LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS THR SEQRES 1 B 350 LYS SER LYS LEU PRO LYS PRO VAL GLN ASP LEU ILE LYS SEQRES 2 B 350 MET ILE PHE ASP VAL GLU SER MET LYS LYS ALA MET VAL SEQRES 3 B 350 GLU TYR GLU ILE ASP LEU GLN LYS MET PRO LEU GLY LYS SEQRES 4 B 350 LEU SER LYS ARG GLN ILE GLN ALA ALA TYR SER ILE LEU SEQRES 5 B 350 SER GLU VAL GLN GLN ALA VAL SER GLN GLY SER SER ASP SEQRES 6 B 350 SER GLN ILE LEU ASP LEU SER ASN ARG PHE TYR THR LEU SEQRES 7 B 350 ILE PRO HIS ASP PHE GLY MET LYS LYS PRO PRO LEU LEU SEQRES 8 B 350 ASN ASN ALA ASP SER VAL GLN ALA LYS ALA GLU MET LEU SEQRES 9 B 350 ASP ASN LEU LEU ASP ILE GLU VAL ALA TYR SER LEU LEU SEQRES 10 B 350 ARG GLY GLY SER ASP ASP SER SER LYS ASP PRO ILE ASP SEQRES 11 B 350 VAL ASN TYR GLU LYS LEU LYS THR ASP ILE LYS VAL VAL SEQRES 12 B 350 ASP ARG ASP SER GLU GLU ALA GLU ILE ILE ARG LYS TYR SEQRES 13 B 350 VAL LYS ASN THR HIS ALA THR THR HIS ASN ALA TYR ASP SEQRES 14 B 350 LEU GLU VAL ILE ASP ILE PHE LYS ILE GLU ARG GLU GLY SEQRES 15 B 350 GLU CYS GLN ARG TYR LYS PRO PHE LYS GLN LEU HIS ASN SEQRES 16 B 350 ARG ARG LEU LEU TRP HIS GLY SER ARG THR THR ASN PHE SEQRES 17 B 350 ALA GLY ILE LEU SER GLN GLY LEU ARG ILE ALA PRO PRO SEQRES 18 B 350 GLU ALA PRO VAL THR GLY TYR MET PHE GLY LYS GLY ILE SEQRES 19 B 350 TYR PHE ALA ASP MET VAL SER LYS SER ALA ASN TYR CYS SEQRES 20 B 350 HIS THR SER GLN GLY ASP PRO ILE GLY LEU ILE LEU LEU SEQRES 21 B 350 GLY GLU VAL ALA LEU GLY ASN MET TYR GLU LEU LYS HIS SEQRES 22 B 350 ALA SER HIS ILE SER LYS LEU PRO LYS GLY LYS HIS SER SEQRES 23 B 350 VAL LYS GLY LEU GLY LYS THR THR PRO ASP PRO SER ALA SEQRES 24 B 350 ASN ILE SER LEU ASP GLY VAL ASP VAL PRO LEU GLY THR SEQRES 25 B 350 GLY ILE SER SER GLY VAL ASN ASP THR SER LEU LEU TYR SEQRES 26 B 350 ASN GLU TYR ILE VAL TYR ASP ILE ALA GLN VAL ASN LEU SEQRES 27 B 350 LYS TYR LEU LEU LYS LEU LYS PHE ASN PHE LYS THR HET 1WI A1101 34 HET SO4 A1102 5 HET SO4 A1103 5 HET 1WI B1101 34 HET SO4 B1102 5 HET SO4 B1103 5 HET SO4 B1104 5 HETNAM 1WI 1-[[4-FLUORANYL-3-(3-OXIDANYLIDENE-4-PENTAN-3-YL- HETNAM 2 1WI PIPERAZIN-1-YL)CARBONYL-PHENYL]METHYL]QUINAZOLINE-2,4- HETNAM 3 1WI DIONE HETNAM SO4 SULFATE ION FORMUL 3 1WI 2(C25 H27 F N4 O4) FORMUL 4 SO4 5(O4 S 2-) FORMUL 10 HOH *313(H2 O) HELIX 1 AA1 PRO A 666 PHE A 677 1 12 HELIX 2 AA2 ASP A 678 TYR A 689 1 12 HELIX 3 AA3 PRO A 697 LEU A 701 5 5 HELIX 4 AA4 SER A 702 GLN A 722 1 21 HELIX 5 AA5 SER A 725 ILE A 740 1 16 HELIX 6 AA6 ASN A 754 GLY A 780 1 27 HELIX 7 AA7 ASP A 788 LEU A 797 1 10 HELIX 8 AA8 SER A 808 THR A 821 1 14 HELIX 9 AA9 GLY A 843 LYS A 849 1 7 HELIX 10 AB1 PRO A 850 LYS A 852 5 3 HELIX 11 AB2 ARG A 865 THR A 867 5 3 HELIX 12 AB3 ASN A 868 GLY A 876 1 9 HELIX 13 AB4 PRO A 885 TYR A 889 5 5 HELIX 14 AB5 MET A 900 TYR A 907 1 8 HELIX 15 AB6 PRO A 958 ASN A 961 5 4 HELIX 16 AB7 ASP A 993 ALA A 995 5 3 HELIX 17 AB8 PRO B 666 PHE B 677 1 12 HELIX 18 AB9 ASP B 678 TYR B 689 1 12 HELIX 19 AC1 PRO B 697 LEU B 701 5 5 HELIX 20 AC2 SER B 702 GLN B 722 1 21 HELIX 21 AC3 SER B 725 ILE B 740 1 16 HELIX 22 AC4 ASN B 754 GLY B 780 1 27 HELIX 23 AC5 ASP B 788 LYS B 796 1 9 HELIX 24 AC6 SER B 808 THR B 821 1 14 HELIX 25 AC7 ALA B 823 ASN B 827 5 5 HELIX 26 AC8 GLY B 843 LYS B 849 1 7 HELIX 27 AC9 PRO B 850 LYS B 852 5 3 HELIX 28 AD1 ARG B 865 THR B 867 5 3 HELIX 29 AD2 ASN B 868 GLY B 876 1 9 HELIX 30 AD3 PRO B 885 TYR B 889 5 5 HELIX 31 AD4 MET B 900 ASN B 906 1 7 HELIX 32 AD5 TYR B 907 HIS B 909 5 3 HELIX 33 AD6 PRO B 958 ASN B 961 5 4 HELIX 34 AD7 ASP B 993 ALA B 995 5 3 SHEET 1 AA1 5 THR A 799 VAL A 803 0 SHEET 2 AA1 5 TYR A 829 ARG A 841 -1 O LYS A 838 N LYS A 802 SHEET 3 AA1 5 VAL A 997 PHE A1009 -1 O LYS A1004 N ILE A 834 SHEET 4 AA1 5 ILE A 916 ALA A 925 -1 N ILE A 919 O LEU A1003 SHEET 5 AA1 5 ARG A 857 SER A 864 -1 N HIS A 862 O LEU A 920 SHEET 1 AA2 4 ILE A 895 PHE A 897 0 SHEET 2 AA2 4 GLU A 988 VAL A 991 -1 O VAL A 991 N ILE A 895 SHEET 3 AA2 4 SER A 947 GLY A 950 -1 N VAL A 948 O ILE A 990 SHEET 4 AA2 4 MET A 929 LEU A 932 1 N TYR A 930 O SER A 947 SHEET 1 AA3 3 GLY A 974 SER A 976 0 SHEET 2 AA3 3 GLY A 952 PRO A 956 -1 N THR A 955 O ILE A 975 SHEET 3 AA3 3 LEU A 984 TYR A 986 1 O LEU A 985 N THR A 954 SHEET 1 AA4 2 ILE A 962 LEU A 964 0 SHEET 2 AA4 2 VAL A 967 VAL A 969 -1 O VAL A 969 N ILE A 962 SHEET 1 AA5 5 THR B 799 VAL B 803 0 SHEET 2 AA5 5 TYR B 829 ARG B 841 -1 O LYS B 838 N LYS B 802 SHEET 3 AA5 5 VAL B 997 PHE B1009 -1 O LEU B1002 N PHE B 837 SHEET 4 AA5 5 ILE B 916 ALA B 925 -1 N ILE B 919 O LEU B1003 SHEET 5 AA5 5 ARG B 857 SER B 864 -1 N HIS B 862 O LEU B 920 SHEET 1 AA6 4 ILE B 895 PHE B 897 0 SHEET 2 AA6 4 GLU B 988 VAL B 991 -1 O VAL B 991 N ILE B 895 SHEET 3 AA6 4 SER B 947 GLY B 950 -1 N GLY B 950 O GLU B 988 SHEET 4 AA6 4 MET B 929 LEU B 932 1 N TYR B 930 O SER B 947 SHEET 1 AA7 3 GLY B 974 SER B 976 0 SHEET 2 AA7 3 GLY B 952 PRO B 956 -1 N THR B 955 O ILE B 975 SHEET 3 AA7 3 LEU B 984 TYR B 986 1 O LEU B 985 N THR B 954 SHEET 1 AA8 2 ILE B 962 LEU B 964 0 SHEET 2 AA8 2 VAL B 967 VAL B 969 -1 O VAL B 969 N ILE B 962 CRYST1 48.428 92.007 162.805 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020649 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010869 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006142 0.00000